What's behind the often cryptic symbols used by historic watchmakers? Here are some that are particularly interesting or ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

To recap, it seems Musk didn't initially realise that the X logo was a unicode character. That's because the design was put ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

All Canva designs are ideal for social media posts, invitations, t-shirts, presentations, flyers, you name it. The only thing missing is a 'logo-only' subscription package. Customizing your ...

GSK has shifted towards a global marketing model ... Without standards, people using the content outside of the global don’t have the guidance they need to produce quality material, he said.

Kruti Berawala examines Tata’s decision to merge Vistara into Air India, a move that seeks to blend Air India’s legacy with ...

Immunocore, one of UK biotech's brightest hopes, has selected a third target as part of its immuno-oncology partnership with GlaxoSmithKline. The collaboration was first launched in 2013, and is ...

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update. Strengthened Cash, Strategic Refocus and Pipeline Progress De ...

BRENTFORD, Britain (AP) — BRENTFORD, Britain (AP) — GSK plc (GSK) on Wednesday reported a loss of $75.4 million in its third quarter. The Brentford, Britain-based company said it had a loss of ...

GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...